Interventions in chronic total occlusions with bifurcation lesions: incidence, treatment, and in-hospital outcome

Nikolaos V Konstantinidis1, Bernard Chevalier2, Thomas Hovasse2

  • 1Département de Cardiologie Interventionnelle, Institut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France; Interventional Cardiology Department, St Luke's Hospital, Thessaloniki, Greece.

Insights

Percutaneous coronary intervention for coronary chronic total occlusions (CTO) involving bifurcation lesions (BIF-CTO) is common. Higher complexity in BIF-CTO does not impact procedural success or complication rates with provisional stenting.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research

Background:

  • Coronary chronic total occlusions (CTO) represent a complex subset of coronary artery disease.
  • CTO lesions involving bifurcations (BIF-CTO) are particularly challenging and less studied.
  • Percutaneous coronary intervention (PCI) is a key revascularization strategy for CTO.

Purpose of the Study:

  • To analyze the incidence of BIF-CTO in contemporary PCI procedures.
  • To evaluate procedural strategies, in-hospital outcomes, and complications associated with BIF-CTO PCI.
  • To compare outcomes between BIF-CTO and non-BIF-CTO patient groups.

Main Methods:

  • Retrospective analysis of 607 consecutive CTO patients treated between January 2015 and February 2020.
  • Comparison of procedural strategies, outcomes, and complications between BIF-CTO (n=245) and non-BIF-CTO (n=362) subgroups.
  • Assessment of lesion complexity using J-CTO and PROGRESS-CTO scores.

Main Results:

  • Bifurcation lesions were present in 40.4% of CTO PCI procedures.
  • BIF-CTO patients exhibited higher lesion complexity (higher J-CTO and PROGRESS-CTO scores).
  • Procedural success rates (78.9% overall) were similar between BIF-CTO (80.4%) and non-BIF-CTO (77.8%) groups, irrespective of bifurcation site. Complication rates were comparable.

Conclusions:

  • Bifurcation involvement is frequent in modern CTO PCI.
  • Despite increased complexity, BIF-CTO PCI achieves comparable procedural success and complication rates to non-BIF-CTO.
  • The predominant provisional stenting strategy is effective for BIF-CTO, regardless of lesion complexity.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
13
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
12
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
174